Schedule 13G filing

Vanguard Capital Management LLC cut its CABA stake below 5%

Schedule 13G · Filed Oct 30, 2026

Vanguard Capital Management LLC reported owning 3.8% of Cabaletta Bio, Inc. (CABA) (8,187,183 shares) in a Schedule 13G filed Oct 30, 2026.

A 13G is a passive stake: the holder does not plan to push for changes.

Exited

Cabaletta Bio, Inc.

Stake

3.8% stake

Share this trade

From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.